BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cleynen I, González JR, Figueroa C, Franke A, McGovern D, Bortlík M, Crusius BJ, Vecchi M, Artieda M, Szczypiorska M. Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBDchip European Project. Gut. 2013;62:1556-1565. [PMID: 23263249 DOI: 10.1136/gutjnl-2011-300777] [Cited by in Crossref: 166] [Cited by in F6Publishing: 155] [Article Influence: 16.6] [Reference Citation Analysis]
Number Citing Articles
1 Liu JZ, Anderson CA. Genetic studies of Crohn's disease: past, present and future. Best Pract Res Clin Gastroenterol. 2014;28:373-386. [PMID: 24913378 DOI: 10.1016/j.bpg.2014.04.009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 8.8] [Reference Citation Analysis]
2 Gonsky R, Fleshner P, Deem RL, Biener-Ramanujan E, Li D, Potdar AA, Bilsborough J, Yang S, McGovern DPB, Targan SR. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease. Gastroenterology 2017;153:219-32. [PMID: 28400196 DOI: 10.1053/j.gastro.2017.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
3 Liu Z, Shen B. Overcoming difficulty in diagnosis and differential diagnosis of Crohn's disease: the potential role of serological and genetic tests. Expert Rev Mol Diagn 2015;15:1133-41. [PMID: 26295589 DOI: 10.1586/14737159.2015.1068121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Mantzaris GJ. When can we cure Crohn's? Best Practice & Research Clinical Gastroenterology 2014;28:519-29. [DOI: 10.1016/j.bpg.2014.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Glapa-Nowak A, Szczepanik M, Iwańczak B, Kwiecień J, Szaflarska-Popławska AB, Grzybowska-Chlebowczyk U, Osiecki M, Dziekiewicz M, Stawarski A, Kierkuś J, Banasiewicz T, Banaszkiewicz A, Walkowiak J. Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study. World J Gastroenterol 2021; 27(14): 1483-1496 [PMID: 33911469 DOI: 10.3748/wjg.v27.i14.1483] [Reference Citation Analysis]
6 Latella G, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G, Reif S, Speca S, Lawrance IC. Results of the 4th scientific workshop of the ECCO (I): Pathophysiology of intestinal fibrosis in IBD. Journal of Crohn's and Colitis 2014;8:1147-65. [DOI: 10.1016/j.crohns.2014.03.008] [Cited by in Crossref: 101] [Cited by in F6Publishing: 95] [Article Influence: 12.6] [Reference Citation Analysis]
7 Lindholm CR, Siegel CA. Are We Ready to Include Prognostic Factors in Inflammatory Bowel Disease Trials? Curr Pharm Des 2019;25:64-8. [PMID: 30864506 DOI: 10.2174/1381612825666190312113935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chandan JS, Thomas T. The impact of inflammatory bowel disease on oral health. Br Dent J 2017;222:549-53. [PMID: 28387295 DOI: 10.1038/sj.bdj.2017.318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Ha F, Khalil H. Crohn's disease: a clinical update. Therap Adv Gastroenterol. 2015;8:352-359. [PMID: 26557891 DOI: 10.1177/1756283x15592585] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
10 Fowler KJ, Dassopoulos T, Raptis C. Magnetic Resonance Enterography in the Evaluation of Crohnʼs Disease: A Primer for the Gastroenterologist. Inflammatory Bowel Diseases 2014;20:2179-88. [DOI: 10.1097/mib.0000000000000132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Aiba Y, Nakamura M. The role of TL1A and DR3 in autoimmune and inflammatory diseases. Mediators Inflamm 2013;2013:258164. [PMID: 24453414 DOI: 10.1155/2013/258164] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
12 Scharl M, Rogler G, Biedermann L. Fistulizing Crohn's Disease. Clin Transl Gastroenterol. 2017;8:e106. [PMID: 28703786 DOI: 10.1038/ctg.2017.33] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kuenzig ME, Yim J, Coward S, Eksteen B, Seow CH, Barnabe C, Barkema HW, Silverberg MS, Lakatos PL, Beck PL, Fedorak R, Dieleman LA, Madsen K, Panaccione R, Ghosh S, Kaplan GG. The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study. EBioMedicine 2017;21:188-96. [PMID: 28668336 DOI: 10.1016/j.ebiom.2017.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
14 Gale G, Östman S, Rekabdar E, Torinsson Naluai Å, Högkil K, Hasséus B, Saalman R, Jontell M. Characterisation of a Swedish cohort with orofacial granulomatosis with or without Crohn's disease. Oral Dis 2015;21. [DOI: 10.1111/odi.12236] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
15 Branquinho D, Freire P, Sofia C. NOD2 mutations and colorectal cancer - Where do we stand? World J Gastrointest Surg 2016; 8(4): 284-293 [PMID: 27152134 DOI: 10.4240/wjgs.v8.i4.284] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
16 Henry C, Bassignani A, Berland M, Langella O, Sokol H, Juste C. Modern Metaproteomics: A Unique Tool to Characterize the Active Microbiome in Health and Diseases, and Pave the Road towards New Biomarkers—Example of Crohn’s Disease and Ulcerative Colitis Flare-Ups. Cells 2022;11:1340. [DOI: 10.3390/cells11081340] [Reference Citation Analysis]
17 Soubières AA, Poullis A. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:2016-2022. [PMID: 27416044 DOI: 10.1097/mib.0000000000000836] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
18 Palmela C, Torres J, Cravo M. New Trends in Inflammatory Bowel Disease. GE Port J Gastroenterol 2015;22:103-11. [PMID: 28868386 DOI: 10.1016/j.jpge.2015.03.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
19 Meddens CA, van der List ACJ, Nieuwenhuis EES, Mokry M. Non-coding DNA in IBD: from sequence variation in DNA regulatory elements to novel therapeutic potential. Gut 2019;68:928-41. [DOI: 10.1136/gutjnl-2018-317516] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
20 Yassin S, Isakov NF, Ron Y, Cohen NA, Hirsch A, Maharshak N. A watchful waiting approach for newly diagnosed Crohn's disease patients with an inflammatory phenotype. Int J Colorectal Dis 2021;36:735-43. [PMID: 33404768 DOI: 10.1007/s00384-020-03811-8] [Reference Citation Analysis]
21 Maehata Y, Nagata Y, Moriyama T, Matsuno Y, Hirano A, Umeno J, Torisu T, Manabe T, Kitazono T, Esaki M. Risk of surgery in patients with stricturing type of Crohn's disease at the initial diagnosis: a single center experience. Intest Res 2019;17:357-64. [PMID: 30781932 DOI: 10.5217/ir.2018.00107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Kang B, Choe YH. Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target. Pediatr Gastroenterol Hepatol Nutr 2018;21:1-11. [PMID: 29383299 DOI: 10.5223/pghn.2018.21.1.1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
23 Ferrari L, Krane MK, Fichera A. Inflammatory bowel disease surgery in the biologic era. World J Gastrointest Surg 2016; 8(5): 363-370 [PMID: 27231514 DOI: 10.4240/wjgs.v8.i5.363] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
24 Warner N, Burberry A, Pliakas M, McDonald C, Núñez G. A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. J Biol Chem 2014;289:28213-24. [PMID: 25170077 DOI: 10.1074/jbc.M114.574756] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
25 Chang CW, Wong JM, Tung CC, Shih IL, Wang HY, Wei SC. Intestinal stricture in Crohn’s disease. Intest Res. 2015;13:19-26. [PMID: 25691840 DOI: 10.5217/ir.2015.13.1.19] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
26 Lauro A, D'Amico F, Gondolesi G. The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation. Expert Rev Gastroenterol Hepatol 2017;11:1105-17. [PMID: 28805088 DOI: 10.1080/17474124.2017.1367665] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
27 Banasik J, Padysz M, Pawłowicz M, Gąsiorowska A. Does the location of inflammatory lesions in the gastrointestinal tract determine the clinical course of Crohn’s disease? Postępy Higieny i Medycyny Doświadczalnej 2021;75:12-7. [DOI: 10.5604/01.3001.0014.6581] [Reference Citation Analysis]
28 Dieli-Crimi R, Martínez-Gallo M, Franco-Jarava C, Antolin M, Blasco L, Paramonov I, Semidey ME, Álvarez Fernández A, Molero X, Velásquez J, Martín-Nalda A, Pujol-Borrell R, Colobran R. Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations. Clin Immunol 2018;195:49-58. [PMID: 30063981 DOI: 10.1016/j.clim.2018.07.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
29 Zhang YW, Xu XY, Zhang J, Yao X, Lu C, Chen CX, Yu CH, Sun J. Missense mutation in PRKCQ is associated with Crohn's disease. J Dig Dis 2019;20:243-7. [DOI: 10.1111/1751-2980.12717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Valatas V, Kolios G, Bamias G. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity. Front Immunol 2019;10:583. [PMID: 30972074 DOI: 10.3389/fimmu.2019.00583] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
31 Gerich ME, McGovern DP. Towards personalized care in IBD. Nat Rev Gastroenterol Hepatol. 2014;11:287-299. [PMID: 24345887 DOI: 10.1038/nrgastro.2013.242] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
32 Pittet V, Michetti P, Mueller C, Braegger CP, von Känel R, Schoepfer A, Macpherson AJ, Rogler G, Anderegg C, Bauerfeind P, Beglinger C, Begré S, Belli D, Bengoa JM, Biedermann L, Bigler B, Binek J, Blattmann M, Boehm S, Borovicka J, Braegger CP, Brunner N, Bühr P, Burnand B, Burri E, Buyse S, Cremer M, Criblez DH, de Saussure P, Degen L, Delarive J, Doerig C, Dora B, Dorta G, Egger M, Ehmann T, El-wafa A, Engelmann M, Ezri J, Felley C, Fliegner M, Fournier N, Fraga M, Frei P, Frei PR, Fried M, Froehlich F, Funk C, Furlano RI, Gallot-lavallée S, Geyer M, Girardin M, Golay D, Grandinetti T, Gysi B, Haack H, Haarer J, Helbling B, Hengstler P, Herzog D, Hess C, Heyland K, Hinterleitner T, Hiroz P, Hirschi C, Hruz P, Iwata R, Jost R, Juillerat P, Keller C, Knellwolf C, Knoblauch C, Köhler H, Koller R, Krieger-grübel C, Kullak-ublick G, Künzler P, Landolt M, Lange R, Lehmann FS, Macpherson A, Maerten P, Maillard MH, Manser C, Manz M, Marbet U, Marx G, Matter C, Meier R, Mendanova M, Michetti P, Misselwitz B, Morell B, Mosler P, Mottet C, Müller C, Müller P, Müllhaupt B, Münger-beyeler C, Musso L, Nagy A, Neagu M, Nichita C, Niess J, Nydegger A, Obialo N, Oneta C, Oropesa C, Peter U, Peternac D, Petit LM, Piccoli-gfeller F, Pilz JB, Pittet V, Raschle N, Rentsch R, Restellini RS, Richterich J, Rihs S, Ritz MA, Roduit J, Rogler D, Rogler G, Rossel J, Rueger V, Saner G, Sauter B, Sawatzki M, Schäppi M, Scharl M, Scharl S, Schelling M, Schibli S, Schlauri H, Uebelhart SS, Schnegg J, Schoepfer A, Seibold F, Seirafi M, Semadeni G, Semela D, Senning A, Sidler M, Sokollik C, Spalinger J, Spangenberger H, Stadler P, Steuerwald M, Straumann A, Straumann-funk B, Sulz M, Suter A, Thorens J, Tiedemann S, Tutuian R, Vavricka S, Viani F, Vögtlin J, Von Känel R, Vonlaufen A, Vouillamoz D, Vulliamy R, Wermuth J, Werner H, Wiesel P, Wiest R, Wylie T, Zeitz J, Zimmermann D; Swiss IBD Cohort Study Group. Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). International Journal of Epidemiology 2019;48:385-386f. [DOI: 10.1093/ije/dyy298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
33 Leonetti D, Reimund JM, Tesse A, Viennot S, Martinez MC, Bretagne AL, Andriantsitohaina R. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One 2013;8:e73088. [PMID: 24019899 DOI: 10.1371/journal.pone.0073088] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
34 Franzè E, Monteleone I, Laudisi F, Rizzo A, Dinallo V, Di Fusco D, Colantoni A, Ortenzi A, Giuffrida P, Di Carlo S, Sica GS, Di Sabatino A, Monteleone G. Cadherin-11 Is a Regulator of Intestinal Fibrosis. J Crohns Colitis 2020;14:406-17. [PMID: 31504344 DOI: 10.1093/ecco-jcc/jjz147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
35 Verstockt B, Bressler B, Martinez-Lozano H, McGovern D, Silverberg MS. Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management? Gastroenterology 2022;162:1370-82. [PMID: 34995534 DOI: 10.1053/j.gastro.2021.12.246] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhang M, Liu S, Xu J, Lv S, Fan Y, Zhang Y, Zhang Y, Wu Y, Su Y, Yu H, Song S, He J, Li H. TNFSF15 Polymorphisms are Associated with Graves’ Disease and Graves’ Ophthalmopathy in a Han Chinese Population. Current Eye Research 2020;45:888-95. [DOI: 10.1080/02713683.2019.1705494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Gabbani T, Deiana S, Marocchi M, Annese V. Genetic risk variants as therapeutic targets for Crohn's disease. Expert Opin Ther Targets 2017;21:381-90. [PMID: 28281904 DOI: 10.1080/14728222.2017.1296431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
38 Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol. 2014;11:372-385. [PMID: 24614343 DOI: 10.1038/nrgastro.2014.27] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 11.8] [Reference Citation Analysis]
39 Bruckner RS, Spalinger MR, Barnhoorn MC, Feakins R, Fuerst A, Jehle EC, Rickenbacher A, Turina M, Niechcial A, Lang S, Hawinkels LJAC, van der Meulen-de Jong AE, Verspaget HW, Rogler G, Scharl M. Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-α Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells. Inflamm Bowel Dis 2021;27:538-49. [PMID: 33146394 DOI: 10.1093/ibd/izaa240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Wu Y, Shen J. Innate Lymphoid Cells in Crohn's Disease. Front Immunol 2020;11:554880. [PMID: 33329513 DOI: 10.3389/fimmu.2020.554880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Wang M, Picco MF. Crohn's Disease. Gastroenterology Clinics of North America 2017;46:449-61. [DOI: 10.1016/j.gtc.2017.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
42 Forni D, Cleynen I, Ferrante M, Cassinotti A, Cagliani R, Ardizzone S, Vermeire S, Fichera M, Lombardini M, Maconi G. ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior. J Crohns Colitis. 2014;8:489-494. [PMID: 24268527 DOI: 10.1016/j.crohns.2013.10.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
43 Lahat A, Veisman I. Capsule Endoscopy in Crohn's Disease-From a Relative Contraindication to Habitual Monitoring Tool. Diagnostics (Basel) 2021;11:1737. [PMID: 34679435 DOI: 10.3390/diagnostics11101737] [Reference Citation Analysis]
44 Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, Brant SR, Cho JH, Daly MJ, Dubinsky M, Duerr RH, Ferguson LR, Franke A, Gearry RB, Goyette P, Hakonarson H, Halfvarson J, Hov JR, Huang H, Kennedy NA, Kupcinskas L, Lawrance IC, Lee JC, Satsangi J, Schreiber S, Théâtre E, van der Meulen-de Jong AE, Weersma RK, Wilson DC, Parkes M, Vermeire S, Rioux JD, Mansfield J, Silverberg MS, Radford-Smith G, McGovern DP, Barrett JC, Lees CW; International Inflammatory Bowel Disease Genetics Consortium. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet 2016;387:156-67. [PMID: 26490195 DOI: 10.1016/S0140-6736(15)00465-1] [Cited by in Crossref: 394] [Cited by in F6Publishing: 191] [Article Influence: 56.3] [Reference Citation Analysis]
45 Dhaliwal J, Walters TD, Mack DR, Huynh HQ, Jacobson K, Otley AR, Debruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Seidman E, Jantchou P, Ricciuto A, Rashid M, Muise AM, Wine E, Carroll M, Lawrence S, Van Limbergen J, Benchimol EI, Church P, Griffiths AM. Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network. J Crohns Colitis 2020;14:445-54. [PMID: 31136648 DOI: 10.1093/ecco-jcc/jjz106] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
46 Lauro ML, Burch JM, Grimes CL. The effect of NOD2 on the microbiota in Crohn's disease. Curr Opin Biotechnol 2016;40:97-102. [PMID: 27035071 DOI: 10.1016/j.copbio.2016.02.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
47 Long WY, Zhan LL, Chen L, Lv XP. Association of 10q21 gene rs10761659 polymorphism with susceptibility to inflammatory bowel disease in a Guangxi Zhuang population. Shijie Huaren Xiaohua Zazhi 2013; 21(29): 3146-3152 [DOI: 10.11569/wcjd.v21.i29.3146] [Reference Citation Analysis]
48 Bossuyt P, Debeuckelaere C, Ferrante M, de Buck van Overstraeten A, Vanbeckevoort D, Billiet T, Wolthuis A, Cleynen I, Van Assche G, D’hoore A, Vermeire S. Risk Stratification for Surgery in Stricturing Ileal Crohn’s Disease: The BACARDI Risk Model. Journal of Crohn's and Colitis 2018;12:32-8. [DOI: 10.1093/ecco-jcc/jjx110] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
49 Chong Y, Han C, Li J, Long X. Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019. J Int Med Res 2020;48:300060520965824. [PMID: 33115290 DOI: 10.1177/0300060520965824] [Reference Citation Analysis]
50 Peyrin-biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, Colombel J, Hanauer SB, Rycroft B. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clinical Gastroenterology and Hepatology 2016;14:348-354.e17. [DOI: 10.1016/j.cgh.2015.06.001] [Cited by in Crossref: 186] [Cited by in F6Publishing: 169] [Article Influence: 31.0] [Reference Citation Analysis]
51 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Reference Citation Analysis]
52 Brand S. Moving the genetics of inflammatory bowel diseases from bench to bedside: first steps towards personalised medicine. Gut 2013;62:1531-3. [PMID: 23363782 DOI: 10.1136/gutjnl-2012-304151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
53 Liefferinckx C, Franchimont D. Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018;24:1428-39. [PMID: 29788122 DOI: 10.1093/ibd/izy109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
54 Panés J, Rimola J. Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol 2017;14:652-64. [PMID: 28790453 DOI: 10.1038/nrgastro.2017.104] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 15.4] [Reference Citation Analysis]
55 Choi CS, Berg AS, Sangster W, Schieffer KM, Harris LR, Deiling SM, Koltun WA. Combined Medical and Surgical Approach Improves Healing of Septic Perianal Crohn's Disease. Journal of the American College of Surgeons 2016;223:506-514.e1. [DOI: 10.1016/j.jamcollsurg.2016.05.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
56 Berg DR, Colombel JF, Ungaro R. The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1896-905. [PMID: 30934053 DOI: 10.1093/ibd/izz059] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
57 Arora U, Kedia S, Garg P, Bopanna S, Jain S, Yadav DP, Goyal S, Gupta V, Sahni P, Pal S, Dash NR, Madhusudhan KS, Sharma R, Makharia G, Ahuja V. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease. Dig Dis Sci. 2018;63:1592-1599. [PMID: 29611078 DOI: 10.1007/s10620-018-5041-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Damas OM, Gomez L, Quintero MA, Rampersaud E, Slifer S, Beecham GW, Kerman DH, Deshpande AR, Sussman DA, Abreu MT, McCauley JL. Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort. Clin Transl Gastroenterol 2017;8:e87. [PMID: 28406493 DOI: 10.1038/ctg.2017.13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
59 Gisbert-Ferrándiz L, Salvador P, Ortiz-Masiá D, Macías-Ceja DC, Orden S, Esplugues JV, Calatayud S, Hinojosa J, Barrachina MD, Hernández C. A Single Nucleotide Polymorphism in the Vitamin D Receptor Gene Is Associated With Decreased Levels of the Protein and a Penetrating Pattern in Crohn's Disease. Inflamm Bowel Dis 2018;24:1462-70. [PMID: 29788141 DOI: 10.1093/ibd/izy094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
60 Naftali T, Reshef L, Kovacs A, Porat R, Amir I, Konikoff FM, Gophna U. Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohnʼs Disease: . Inflammatory Bowel Diseases 2016;22:293-302. [DOI: 10.1097/mib.0000000000000662] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
61 Verstockt B, Smith KG, Lee JC. Genome-wide association studies in Crohn's disease: Past, present and future. Clin Transl Immunology. 2018;7:e1001. [PMID: 29484179 DOI: 10.1002/cti2.1001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
62 Roggenbuck D, Reinhold D, Baumgart D, Schierack P, Conrad K, Laass M. Autoimmunity in Crohn's Disease—A Putative Stratification Factor of the Clinical Phenotype. Elsevier; 2016. pp. 77-101. [DOI: 10.1016/bs.acc.2016.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
63 Rieder F, Latella G, Magro F, Yuksel ES, Higgins PDR, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d’Hoore A, Pellino G, Dignass AU. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. ECCOJC 2016;10:873-85. [DOI: 10.1093/ecco-jcc/jjw055] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 17.0] [Reference Citation Analysis]
64 Dragasevic S, Stankovic B, Milosavljevic T, Sokic-Milutinovic A, Lukic S, Alempijevic T, Zukic B, Kotur N, Nikcevic G, Pavlovic S, Popovic D. Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2017;29:909-15. [PMID: 28452812 DOI: 10.1097/MEG.0000000000000877] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
65 Bilsborough J, Targan SR, Snapper SB. Therapeutic Targets in Inflammatory Bowel Disease: Current and Future. Am J Gastroenterol Suppl 2016;3:27-37. [DOI: 10.1038/ajgsup.2016.18] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
66 Buisson A, Douadi C, Ouchchane L, Goutte M, Hugot JP, Dubois A, Minet-Quinard R, Bouvier D, Bommelaer G, Vazeille E, Barnich N. Macrophages Inability to Mediate Adherent-Invasive E. coli Replication is Linked to Autophagy in Crohn's Disease Patients. Cells 2019;8:E1394. [PMID: 31694333 DOI: 10.3390/cells8111394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
67 Park HJ, Jung ES, Kong KA, Park EM, Cheon JH, Choi JH. Identification of OCTN2 variants and their association with phenotypes of Crohn's disease in a Korean population. Sci Rep 2016;6:22887. [PMID: 26965072 DOI: 10.1038/srep22887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
68 Fong SC, Irving PM. Distinct management issues with Crohn's disease of the small intestine. Curr Opin Gastroenterol. 2015;31:92-97. [PMID: 25594888 DOI: 10.1097/mog.0000000000000149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
69 Nguyen MTT, Ali A, Bodkin RP. Small Bowel Volvulus as Delayed Presentation of Undiagnosed Crohn's Disease: A Case Report. Clin Pract Cases Emerg Med 2021;5:455-8. [PMID: 34813443 DOI: 10.5811/cpcem.2021.8.53524] [Reference Citation Analysis]
70 Giuffrida P, Pinzani M, Corazza GR, Di Sabatino A. Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel disease. United European Gastroenterol J 2016;4:523-30. [PMID: 27536362 DOI: 10.1177/2050640616640160] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
71 O'Donnell S, Borowski K, Espin-Garcia O, Milgrom R, Kabakchiev B, Stempak J, Panikkath D, Eksteen B, Xu W, Steinhart AH, Kaplan GG, McGovern DPB, Silverberg MS. The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience. Inflamm Bowel Dis 2019;25:1541-9. [PMID: 30801121 DOI: 10.1093/ibd/izz016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
72 Satta R, Pes GM, Rocchi C, Pes MC, Dore MP. Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease? J Dermatolog Treat 2019;30:612-6. [PMID: 30244616 DOI: 10.1080/09546634.2018.1527998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
73 Yamamoto-furusho JK, Fonseca-camarillo G. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:2683-95. [DOI: 10.1097/mib.0000000000000500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
74 Zorzi F, Calabrese E, Monteleone G. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease. Clin Sci (Lond) 2015;129:1107-13. [PMID: 26494636 DOI: 10.1042/CS20150472] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
75 Zhang J, Chen J, Gu J, Guo H, Chen W. Association of IL23R and ATG16L1 with susceptibility of Crohn’s disease in Chinese population. Scandinavian Journal of Gastroenterology 2014;49:1201-6. [DOI: 10.3109/00365521.2014.936031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
76 Billiet T, Ferrante M, Van Assche G. The use of prognostic factors in inflammatory bowel diseases. Curr Gastroenterol Rep. 2014;16:416. [PMID: 25262067 DOI: 10.1007/s11894-014-0416-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
77 Dulai PS, Singh S, Vande Casteele N, Boland BS, Rivera-Nieves J, Ernst PB, Eckmann L, Barrett KE, Chang JT, Sandborn WJ. Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases? Clin Gastroenterol Hepatol 2019;17:2634-43. [PMID: 31009791 DOI: 10.1016/j.cgh.2019.04.040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
78 Zhang H, Zeng Z, Mukherjee A, Shen B. Molecular diagnosis and classification of inflammatory bowel disease. Expert Rev Mol Diagn. 2018;18:867-886. [PMID: 30152711 DOI: 10.1080/14737159.2018.1516549] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
79 Liu TC, Stappenbeck TS. Genetics and Pathogenesis of Inflammatory Bowel Disease. Annu Rev Pathol. 2016;11:127-148. [PMID: 26907531 DOI: 10.1146/annurev-pathol-012615-044152] [Cited by in Crossref: 127] [Cited by in F6Publishing: 117] [Article Influence: 21.2] [Reference Citation Analysis]
80 Pierre N, Salée C, Vieujean S, Bequet E, Merli AM, Siegmund B, Meuwis MA, Louis E. Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology. Aliment Pharmacol Ther 2021;54:779-91. [PMID: 34297423 DOI: 10.1111/apt.16536] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Ellinghaus D, Bethune J, Petersen BS, Franke A. The genetics of Crohn’s disease and ulcerative colitis--status quo and beyond. Scand J Gastroenterol. 2015;50:13-23. [PMID: 25523552 DOI: 10.3109/00365521.2014.990507] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
82 DeLong CG, Kulaylat AN, Kulaylat AS, Hollenbeak CS, Cilley RE, Rocourt DV. Trends and Attributable Costs of Anorectal Involvement in Pediatric Crohn's Disease. J Surg Res 2018;232:113-20. [PMID: 30463706 DOI: 10.1016/j.jss.2018.06.013] [Reference Citation Analysis]
83 Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113:481-517. [PMID: 29610508 DOI: 10.1038/ajg.2018.27] [Cited by in Crossref: 390] [Cited by in F6Publishing: 311] [Article Influence: 97.5] [Reference Citation Analysis]
84 Pernat Drobež C, Ferkolj I, Potočnik U, Repnik K. Crohn's Disease Candidate Gene Alleles Predict Time to Progression from Inflammatory B1 to Stricturing B2, or Penetrating B3 Phenotype. Genet Test Mol Biomarkers 2018;22:143-51. [PMID: 29446656 DOI: 10.1089/gtmb.2017.0210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Naramore SK, Bennett WE Jr, Jiang G, Kugathasan S, Denson LA, Hyams JS, Steiner SJ; PRO-KIIDS Research Group. Serologic, but Not Genetic, Markers Are Associated With Impaired Anthropometrics at Diagnosis of Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr 2019;69:e129-34. [PMID: 31393333 DOI: 10.1097/MPG.0000000000002462] [Reference Citation Analysis]
86 Hargarten JC, Williamson PR. Epigenetic Regulation of Autophagy: A Path to the Control of Autoimmunity. Front Immunol 2018;9:1864. [PMID: 30154791 DOI: 10.3389/fimmu.2018.01864] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
87 Tolentino YFM, Elia PP, Fogaça HS, Carneiro AJV, Zaltman C, Moura-neto R, Luiz RR, Carvalho MDGC, de Souza HS. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn’s Disease Phenotypes in Southeastern Brazilians. Dig Dis Sci 2016;61:2636-47. [DOI: 10.1007/s10620-016-4172-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
88 Chesney KL, Men H, Hankins MA, Bryda EC. The Atg16l1 gene: characterization of wild type, knock-in, and knock-out phenotypes in rats. Physiol Genomics 2021;53:269-81. [PMID: 33818130 DOI: 10.1152/physiolgenomics.00114.2020] [Reference Citation Analysis]
89 Kunovsky L, Kala Z, Marek F, Dolina J, Poredska K, Kucerova L, Benesova K, Mitas L. The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease. Int J Colorectal Dis 2019;34:347-51. [PMID: 30069743 DOI: 10.1007/s00384-018-3122-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
90 Bettenworth D, Nowacki TM, Cordes F, Buerke B, Lenze F. Assessment of stricturing Crohn's disease: Current clinical practice and future avenues. World J Gastroenterol 2016; 22(3): 1008-1016 [PMID: 26811643 DOI: 10.3748/wjg.v22.i3.1008] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
91 Borg-Bartolo SP, Boyapati RK, Satsangi J, Kalla R. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Res. 2020;9. [PMID: 32047622 DOI: 10.12688/f1000research.20928.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
92 Atreya R, Siegmund B. Location is important: differentiation between ileal and colonic Crohn's disease. Nat Rev Gastroenterol Hepatol 2021;18:544-58. [PMID: 33712743 DOI: 10.1038/s41575-021-00424-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
93 Stankovic B, Kotur N, Nikcevic G, Gasic V, Zukic B, Pavlovic S. Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications. Genes (Basel) 2021;12:1438. [PMID: 34573420 DOI: 10.3390/genes12091438] [Reference Citation Analysis]
94 Adolph TE, Tomczak MF, Niederreiter L, Ko HJ, Böck J, Martinez-Naves E, Glickman JN, Tschurtschenthaler M, Hartwig J, Hosomi S. Paneth cells as a site of origin for intestinal inflammation. Nature. 2013;503:272-276. [PMID: 24089213 DOI: 10.1038/nature12599] [Cited by in Crossref: 421] [Cited by in F6Publishing: 391] [Article Influence: 46.8] [Reference Citation Analysis]
95 Hu S, Peng L, Kwak YT, Tekippe EM, Pasare C, Malter JS, Hooper LV, Zaki MH. The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense. Cell Rep 2015;13:1922-36. [PMID: 26655906 DOI: 10.1016/j.celrep.2015.10.040] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
96 Coelho R, Ribeiro H, Maconi G. Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Inflamm Bowel Dis. 2017;23:23-34. [PMID: 28002125 DOI: 10.1097/mib.0000000000000997] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
97 Lauro ML, D'Ambrosio EA, Bahnson BJ, Grimes CL. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2. ACS Infect Dis 2017;3:264-70. [PMID: 27748583 DOI: 10.1021/acsinfecdis.6b00154] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
98 Stappenbeck TS, McGovern DPB. Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease. Gastroenterology 2017;152:322-6. [PMID: 27729212 DOI: 10.1053/j.gastro.2016.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
99 O'Brien SJ, Hallion J, Scheurlen KM, Fiechter C, Burton J, Paas M, Schmidt M, Gardner S, Eichenberger MR, Pan J, Rai S, Galandiuk S. Crohn's disease-related single nucleotide polymorphisms are associated with ileal pouch afferent limb stenosis. J Gastrointest Surg 2021. [PMID: 33443688 DOI: 10.1007/s11605-020-04884-0] [Reference Citation Analysis]
100 Torres J, Caprioli F, Katsanos KH, Lobatón T, Micic D, Zerôncio M, Van Assche G, Lee JC, Lindsay JO, Rubin DT, Panaccione R, Colombel JF. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis 2016;10:1385-94. [PMID: 27282402 DOI: 10.1093/ecco-jcc/jjw116] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
101 Maldonado-Contreras A, Ferrer L, Cawley C, Crain S, Bhattarai S, Toscano J, Ward DV, Hoffman A. Dysbiosis in a canine model of human fistulizing Crohn's disease. Gut Microbes 2020;12:1785246. [PMID: 32730134 DOI: 10.1080/19490976.2020.1785246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Michail S, Bultron G, Depaolo RW. Genetic variants associated with Crohn's disease. Appl Clin Genet 2013;6:25-32. [PMID: 23935379 DOI: 10.2147/TACG.S33966] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
103 Verstockt B, Cleynen I. Genetic Influences on the Development of Fibrosis in Crohn's Disease. Front Med (Lausanne) 2016;3:24. [PMID: 27303667 DOI: 10.3389/fmed.2016.00024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
104 Halligan S, Boone D, Archer L, Ahmad T, Bloom S, Rodriguez-Justo M, Taylor SA, Mallett S. Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review. Health Technol Assess 2021;25:1-66. [PMID: 34225839 DOI: 10.3310/hta25450] [Reference Citation Analysis]
105 de Lange KM, Barrett JC. Understanding inflammatory bowel disease via immunogenetics. J Autoimmun 2015;64:91-100. [PMID: 26257098 DOI: 10.1016/j.jaut.2015.07.013] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 12.4] [Reference Citation Analysis]
106 Sandahl TD, Kelsen J, Dige A, Dahlerup JF, Agnholt J, Hvas CL, Thiel S. The lectin pathway of the complement system is downregulated in Crohn's disease patients who respond to anti-TNF-α therapy. J Crohns Colitis 2014;8:521-8. [PMID: 24291022 DOI: 10.1016/j.crohns.2013.11.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
107 Willoughby JMT. Crohn's disease and sarcoidosis in siblings: follow-up of a published report with a new case and brief review of the literature. Frontline Gastroenterol 2017;8:74-7. [PMID: 28839888 DOI: 10.1136/flgastro-2015-100666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
108 Juyal G, Sood A, Midha V, Thelma BK. Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies. J Genet 2018;97:1493-507. [DOI: 10.1007/s12041-018-1015-8] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
109 de Bruyn M, Vermeire S. NOD2 and bacterial recognition as therapeutic targets for Crohn’s disease. Expert Opinion on Therapeutic Targets 2017;21:1123-39. [DOI: 10.1080/14728222.2017.1397627] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
110 Schnitzler F, Friedrich M, Angelberger M, Diegelmann J, Stallhofer J, Wolf C, Dütschler J, Truniger S, Olszak T, Beigel F, Tillack C, Lohse P, Brand S. Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn's disease and active smoking status resulting in ileal stenosis requiring surgery. PLoS One 2020;15:e0236421. [PMID: 32716958 DOI: 10.1371/journal.pone.0236421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Wu W, He C, Liu C, Cao AT, Xue X, Evans-Marin HL, Sun M, Fang L, Yao S, Pinchuk IV. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD. Gut. 2015;64:1755-1764. [PMID: 25281418 DOI: 10.1136/gutjnl-2014-307980] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 10.6] [Reference Citation Analysis]
112 de Bruyn M, Vandooren J, Ugarte-berzal E, Arijs I, Vermeire S, Opdenakker G. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 2016;51:295-358. [DOI: 10.1080/10409238.2016.1199535] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
113 Omarjee O, Mathieu AL, Quiniou G, Moreews M, Ainouze M, Frachette C, Melki I, Dumaine C, Gerfaud-Valentin M, Duquesne A, Kallinich T, Tahir Turanli E, Malcus C, Viel S, Pescarmona R, Georgin-Lavialle S, Jamilloux Y, Larbre JP, Sarrabay G, Magnotti F, Rice GI, Bleicher F, Reboulet J, Merabet S, Henry T, Crow YJ, Faure M, Walzer T, Belot A. LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages. J Exp Med 2021;218:e20201006. [PMID: 33606008 DOI: 10.1084/jem.20201006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Hart AL, Ng SC. Crohn's disease. Medicine 2015;43:282-90. [DOI: 10.1016/j.mpmed.2015.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
115 Siegmund B, Feakins RM, Barmias G, Ludvig JC, Teixeira FV, Rogler G, Scharl M. Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease. J Crohns Colitis. 2016;10:377-386. [PMID: 26681764 DOI: 10.1093/ecco-jcc/jjv228] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
116 Schmoyer CJ, Saidman J, Bohl JL, Bierly CL, Kuemmerle JF, Bickston SJ. The Pathogenesis and Clinical Management of Stricturing Crohn Disease. Inflamm Bowel Dis 2021:izab038. [PMID: 33693860 DOI: 10.1093/ibd/izab038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
117 Lee YJ, Kim KM, Jang JY, Song K. Association of TNFSF15 polymorphisms in Korean children with Crohn's disease. Pediatr Int 2015;57:1149-53. [PMID: 25998826 DOI: 10.1111/ped.12686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
118 Ma C, Storer CE, Chandran U, LaFramboise WA, Petrosko P, Frank M, Hartman DJ, Pantanowitz L, Haritunians T, Head RD, Liu TC. Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer. EBioMedicine 2021;67:103347. [PMID: 33906066 DOI: 10.1016/j.ebiom.2021.103347] [Reference Citation Analysis]
119 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 76] [Article Influence: 13.0] [Reference Citation Analysis]
120 Bouguen G, Levesque BG, Feagan BG, Kavanaugh A, Peyrin–biroulet L, Colombel J, Hanauer SB, Sandborn WJ. Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease. Clinical Gastroenterology and Hepatology 2015;13:1042-1050.e2. [DOI: 10.1016/j.cgh.2013.09.006] [Cited by in Crossref: 163] [Cited by in F6Publishing: 143] [Article Influence: 23.3] [Reference Citation Analysis]
121 Joosse ME, Aardoom MA, Kemos P, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Tzivinikos C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Ruemmele FM, Garnier-Lengline H, Veres G, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Hussey S, Veereman G, Braegger CP, Trindade E, Wewer AV, Hauer AC, de Vries ACH, Sigall Boneh R, Sarbagili Shabat C, Levine A, de Ridder L, Paediatric IBD Porto group of ESPGHAN. Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN. Aliment Pharmacol Ther. 2018;48:523-537. [PMID: 29984520 DOI: 10.1111/apt.14893] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
122 Choy MC, Visvanathan K, De Cruz P. An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2017;23:2-13. [DOI: 10.1097/mib.0000000000000955] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
123 Pernat Drobež C, Repnik K, Gorenjak M, Ferkolj I, Weersma RK, Potočnik U. DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn's disease. Eur J Gastroenterol Hepatol 2018;30:447-55. [PMID: 29293112 DOI: 10.1097/MEG.0000000000001055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
124 He JS, Tan JY, Li XZ, Feng R, Xiong SS, Lin SN, Qiu Y, Mao R. Serum biomarkers of fibrostenotic Crohn's disease: Where are we now? J Dig Dis 2020;21:336-41. [PMID: 32496631 DOI: 10.1111/1751-2980.12913] [Reference Citation Analysis]
125 Siakavellas SI, Bamias G. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation. Inflamm Bowel Dis 2015;21:2441-52. [PMID: 26099067 DOI: 10.1097/MIB.0000000000000492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
126 Gabbani T, Deiana S, Annese AL, Lunardi S, Annese V. The genetic burden of inflammatory bowel diseases: implications for the clinic? Expert Rev Gastroenterol Hepatol 2016;10:1109-17. [PMID: 27258545 DOI: 10.1080/17474124.2016.1196131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
127 Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 41-50 [PMID: 26855811 DOI: 10.4292/wjgpt.v7.i1.41] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
128 Lee JC. Beyond disease susceptibility-Leveraging genome-wide association studies for new insights into complex disease biology. HLA 2017;90:329-34. [PMID: 29106067 DOI: 10.1111/tan.13170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Cordes F, Foell D, Ding JN, Varga G, Bettenworth D. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease. World J Gastroenterol 2020; 26(28): 4055-4075 [PMID: 32821070 DOI: 10.3748/wjg.v26.i28.4055] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
130 Schnitzler F, Friedrich M, Wolf C, Angelberger M, Diegelmann J, Olszak T, Beigel F, Tillack C, Stallhofer J, Göke B, Glas J, Lohse P, Brand S. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067. PLoS One 2014;9:e108503. [PMID: 25365249 DOI: 10.1371/journal.pone.0108503] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
131 Spekhorst LM, Visschedijk MC, Weersma RK, Festen EA. Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future. Expert Review of Clinical Immunology 2014;11:33-44. [DOI: 10.1586/1744666x.2015.990439] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
132 Teimoori-Toolabi L, Samadpoor S, Mehrtash A, Ghadir M, Vahedi H. Among autophagy genes, ATG16L1 but not IRGM is associated with Crohn's disease in Iranians. Gene 2018;675:176-84. [PMID: 29960072 DOI: 10.1016/j.gene.2018.06.074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
133 Ananthakrishnan AN, Shi HY, Tang W, Law CC, Sung JJ, Chan FK, Ng SC. Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease. J Crohns Colitis 2016;10:1224-36. [PMID: 26928965 DOI: 10.1093/ecco-jcc/jjw054] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
134 Ruemmele F, Veres G, Kolho K, Griffiths A, Levine A, Escher J, Amil Dias J, Barabino A, Braegger C, Bronsky J, Buderus S, Martín-de-carpi J, De Ridder L, Fagerberg U, Hugot J, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López V, Paerregaard A, Russell R, Serban D, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Journal of Crohn's and Colitis 2014;8:1179-207. [DOI: 10.1016/j.crohns.2014.04.005] [Cited by in Crossref: 580] [Cited by in F6Publishing: 470] [Article Influence: 72.5] [Reference Citation Analysis]
135 Subramanian S, Ekbom A, Rhodes JM. Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD? Gut. 2017;66:362-381. [PMID: 27802156 DOI: 10.1136/gutjnl-2016-312673] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
136 Connelly TM, Messaris E. Predictors of recurrence of Crohn’s disease after ileocolectomy: A review. World J Gastroenterol 2014; 20(39): 14393-14406 [PMID: 25339826 DOI: 10.3748/wjg.v20.i39.14393] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
137 Lin SN, Zheng DP, Qiu Y, Zhang SH, He Y, Chen BL, Zeng ZR, Mao R, Chen MH. Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification. Therap Adv Gastroenterol 2020;13:1756284820968732. [PMID: 33329758 DOI: 10.1177/1756284820968732] [Reference Citation Analysis]
138 Wang J, Ortiz C, Fontenot L, Xie Y, Ho W, Mattai SA, Shih DQ, Koon HW. High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures. PLoS One 2020;15:e0231796. [PMID: 32287314 DOI: 10.1371/journal.pone.0231796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
139 Ma T, Wu S, Yan W, Xie R, Zhou C. A functional variant of ATG16L2 is associated with Crohn's disease in the Chinese population. Colorectal Dis 2016;18:O420-6. [PMID: 27611316 DOI: 10.1111/codi.13507] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
140 Mentzer A, Nayee S, Omar Y, Hullah E, Taylor K, Goel R, Bye H, Shembesh T, Elliott TR, Campbell H, Patel P, Nolan A, Mansfield J, Challacombe S, Escudier M, Mathew CG, Sanderson JD, Prescott NJ. Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis. Inflamm Bowel Dis 2016;22:1552-8. [PMID: 27306066 DOI: 10.1097/MIB.0000000000000844] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
141 Rieder F, Fiocchi C, Rogler G. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2017;152:340-350.e6. [PMID: 27720839 DOI: 10.1053/j.gastro.2016.09.047] [Cited by in Crossref: 163] [Cited by in F6Publishing: 149] [Article Influence: 27.2] [Reference Citation Analysis]
142 Sidiq T, Yoshihama S, Downs I, Kobayashi KS. Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease. Front Immunol. 2016;7:367. [PMID: 27703457 DOI: 10.3389/fimmu.2016.00367] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
143 Rogala AR, Schoenborn AA, Fee BE, Cantillana VA, Joyce MJ, Gharaibeh RZ, Roy S, Fodor AA, Sartor RB, Taylor GA, Gulati AS. Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice. Dis Model Mech 2018;11:dmm031070. [PMID: 29361512 DOI: 10.1242/dmm.031070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
144 Goran L, Negreanu AM, Stemate A, Negreanu L. Capsule endoscopy: Current status and role in Crohn’s disease. World J Gastrointest Endosc 2018; 10(9): 184-192 [PMID: 30283601 DOI: 10.4253/wjge.v10.i9.184] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
145 Prescott D, Maisonneuve C, Yadav J, Rubino SJ, Girardin SE, Philpott DJ. NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103+ dendritic cells. Proc Natl Acad Sci U S A 2020;117:10946-57. [PMID: 32350141 DOI: 10.1073/pnas.1912866117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
146 Schnitzler F, Friedrich M, Wolf C, Stallhofer J, Angelberger M, Diegelmann J, Olszak T, Tillack C, Beigel F, Göke B, Glas J, Lohse P, Brand S. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations. PLoS One 2015;10:e0116044. [PMID: 26147989 DOI: 10.1371/journal.pone.0116044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
147 Ye BD, McGovern DP. Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility. Expert Rev Clin Immunol 2016;12:1091-107. [PMID: 27156530 DOI: 10.1080/1744666X.2016.1184972] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
148 Park SC, Jeen YT. Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients. Cells 2019;8:E404. [PMID: 31052430 DOI: 10.3390/cells8050404] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
149 Le Berre C, Peyrin-Biroulet L; SPIRIT-IOIBD study group. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD. Gastroenterology 2021;160:1452-1460.e21. [PMID: 33421515 DOI: 10.1053/j.gastro.2020.10.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
150 Zhao M, Burisch J. Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease. Dig Dis Sci 2019;64:1759-69. [PMID: 31073736 DOI: 10.1007/s10620-019-05648-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
151 Festen EA, Weersma RK. How will insights from genetics translate to clinical practice in inflammatory bowel disease? Best Pract Res Clin Gastroenterol. 2014;28:387-397. [PMID: 24913379 DOI: 10.1016/j.bpg.2014.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
152 Yang D, Yang S, Song K, Hong M, Park SH, Lee H, Kim J, Lee HJ, Park S, Jung KW, Kim K, Ye BD, Byeon J, Myung S, Kim J, Shin US, Yu CS, Lee I. TNFSF15 is an independent predictor for the development of Crohn's disease-related complications in Koreans. Journal of Crohn's and Colitis 2014;8:1315-26. [DOI: 10.1016/j.crohns.2014.04.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
153 Wang MH, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Monroe K, Nix BD, Newberry RD, Faubion WA. Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients. Inflamm Bowel Dis 2021:izaa362. [PMID: 33724339 DOI: 10.1093/ibd/izaa362] [Reference Citation Analysis]
154 Moran CJ, Klein C, Muise AM, Snapper SB. Very early-onset inflammatory bowel disease: gaining insight through focused discovery. Inflamm Bowel Dis. 2015;21:1166-1175. [PMID: 25895007 DOI: 10.1097/mib.0000000000000329] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
155 Juste C, Kreil DP, Beauvallet C, Guillot A, Vaca S, Carapito C, Mondot S, Sykacek P, Sokol H, Blon F. Bacterial protein signals are associated with Crohn's disease. Gut. 2014;63:1566-1577. [PMID: 24436141 DOI: 10.1136/gutjnl-2012-303786] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
156 Valero C, García MJ. Bone Metabolism in Inflammatory Bowel Disease and Celiac Disease. Clinic Rev Bone Miner Metab 2019;17:152-9. [DOI: 10.1007/s12018-019-09269-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
157 Lee H, Cleynen I. Molecular Profiling of IBD Subtypes and Therapy Responses. In: Hedin C, Rioux JD, D'amato M, editors. Molecular Genetics of Inflammatory Bowel Disease. Cham: Springer International Publishing; 2019. pp. 157-82. [DOI: 10.1007/978-3-030-28703-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
158 Ashton JJ, Mossotto E, Ennis S, Beattie RM. Personalising medicine in inflammatory bowel disease-current and future perspectives. Transl Pediatr 2019;8:56-69. [PMID: 30881899 DOI: 10.21037/tp.2018.12.03] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
159 Tsianos VE, Kostoulas C, Gazouli M, Frillingos S, Georgiou I, Christodoulou DK, Katsanos KH, Tsianos EV. ATG16L1 T300A polymorphism is associated with Crohn's disease in a Northwest Greek cohort, but ECM1 T130M and G290S polymorphisms are not associated with ulcerative colitis. Ann Gastroenterol 2020;33:38-44. [PMID: 31892796 DOI: 10.20524/aog.2019.0434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
160 Serban DE. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Nutr Clin Pract 2015;30:760-79. [DOI: 10.1177/0884533615606898] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
161 Lee JC, Biasci D, Roberts R, Gearry RB, Mansfield JC, Ahmad T, Prescott NJ, Satsangi J, Wilson DC, Jostins L, Anderson CA; UK IBD Genetics Consortium, Traherne JA, Lyons PA, Parkes M, Smith KG. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nat Genet. 2017;49:262-268. [PMID: 28067912 DOI: 10.1038/ng.3755] [Cited by in Crossref: 135] [Cited by in F6Publishing: 118] [Article Influence: 27.0] [Reference Citation Analysis]
162 Mak JWY, Lok Tung Ho C, Wong K, Cheng TY, Yip TCF, Leung WK, Li M, Lo FH, Ng KM, Sze SF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Ng SC. Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry. J Crohns Colitis 2021;15:401-8. [PMID: 32914171 DOI: 10.1093/ecco-jcc/jjaa181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
163 Lee HS, Cleynen I. Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making? Cells. 2019;8. [PMID: 31167397 DOI: 10.3390/cells8060535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]